The CB1 receptor antagonist rimonabant reverses the diet‐induced obesity phenotype through the regulation of lipolysis and energy balance

Omar Jbilo, Christine Ravinet‐Trillou, M. Arnone, +8

The FASEB Journal

Energy BalanceMetabolic RemodelingInsulin SignalingAdipose MassObesity +20

Cloning and Characterization of PRAX-1

Sylvaine Galiègue, Omar Jbilo, Thérèse Combes, +4

Journal of Biological Chemistry

Early Quantitative Evaluation of a Tumor Vasculature Disruptive Agent AVE8062 Using Dynamic Contrast-Enhanced Ultrasonography

S. Lavisse, Pascale Lejeune, Valérie Rouffiac, +9

Investigative Radiology

Immunohistochemical Assessment of the Peripheral Benzodiazepine Receptor in Human Tissues

Estelle Bribes, Dominique Carrière, Catherine Goubet, +3

Journal of Histochemistry & Cytochemistry

Molecular PhysiologySignal TransductionBiochemistryG Protein-coupled ReceptorPbr Localization +12

SSR125329A, a high affinity σ receptor ligand with potent anti-inflammatory properties

Bernard Bourrié, Estelle Bribes, Nathalie De Nys, +8

European Journal of Pharmacology

InflammationMolecular PharmacologyAnti-inflammatoryMedicineImmunology +8

Ligands of the peripheral benzodiazepine receptor have therapeutic effects in pneumopathies in vivo

Estelle Bribes, Bernard Bourrié, Pierre Casellas

Immunology Letters

Pharmacological StudyPhysiologyPharmacologyTherapeutic EffectsPharmacological Agent +5

Peripheral Benzodiazepine Receptor Mapping in Rat Kidney. Effects of Angiotensin II-Induced Hypertension

Estelle Bribes, Pierre Casellas, Hubert Vidal, +2

Journal of the American Society of Nephrology

Sigma receptor ligands: applications in inflammation and oncology.

Bernard Bourrié, Estelle Bribes, Jean‐Marie Derocq, +2

PubMed

Sigma ReceptorsSignal TransductionOxysterolBiochemistryG Protein-coupled Receptor +13

Involvement of the peripheral benzodiazepine receptor in the development of rheumatoid arthritis in Mrl/lpr mice

Estelle Bribes, Bernard Bourrié, Martine Esclangon, +3

European Journal of Pharmacology

Rheumatoid DisorderRheumatologyAutoimmune DiseaseMedicineImmunology +5

The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood–brain barrier disruption: Implications for multiple sclerosis treatment

Bernard Bourrié, Estelle Bribes, Martine Esclangon, +5

Proceedings of the National Academy of Sciences

Immune RegulationImmunologyImmunotherapyNeuroinflammationBbb Disruption +18